CFSB · As filed with the SEC
CFSB Bancorp cash flow statement, by quarter
The statement as CFSB Bancorp presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | Q4 FY25 3 months ended Jun 30, 2025 | Q3 FY25 3 months ended Mar 31, 2025 | Q2 FY24 3 months ended Dec 31, 2024 | Q1 FY24 3 months ended Sep 30, 2024 | Q4 FY24 3 months ended Jun 30, 2024 | Q3 FY24 3 months ended Mar 31, 2024 | Q2 FY24 3 months ended Dec 31, 2023 | Q1 FY24 3 months ended Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||
| Net Income | — | — | — | (6,000) | — | — | — | 123,000 |
| Provision for (reversal of) credit losses | — | — | — | — | — | — | — | (166,000) |
| Provision for (reversal of) credit losses | — | — | — | (71,000) | — | — | — | — |
| Amortization of securities, net | — | — | — | 65,000 | — | — | — | 96,000 |
| Net change in deferred loan costs and fees | — | — | — | (6,000) | — | — | — | 30,000 |
| Increase in cash surrender value of bank-owned life insurance | — | — | — | (69,000) | — | — | — | (66,000) |
| Deferred income tax expense | — | — | — | 2,000 | — | — | — | 0 |
| Depreciation and amortization, net | — | — | — | 62,000 | — | — | — | 59,000 |
| ESOP expense | — | — | — | 17,000 | — | — | — | 18,000 |
| Stock-based compensation | — | — | — | 90,000 | — | — | — | 90,000 |
| Net increase in accrued interest receivable | — | — | — | 44,000 | — | — | — | (32,000) |
| Other, net | — | — | — | 238,000 | — | — | — | 284,000 |
| Net cash provided by operating activities | — | — | — | 366,000 | — | — | — | 436,000 |
| Cash flows from investing activities: | ||||||||
| Activity in securities available for sale: | ||||||||
| Maturities, prepayments and calls | — | — | — | 6,000 | — | — | — | 8,000 |
| Activity in securities held to maturity: | ||||||||
| Maturities, prepayments and calls | — | — | — | 4,595,000 | — | — | — | 3,897,000 |
| Purchases | — | — | — | (4,504,000) | — | — | — | (3,861,000) |
| Purchases of Federal Home Loan Bank of Boston stock | — | — | — | 0 | — | — | — | (24,000) |
| Loan originations and payments, net | — | — | — | 2,470,000 | — | — | — | 1,899,000 |
| Additions to premises and equipment | — | — | — | (2,000) | — | — | — | 0 |
| Net cash (used in) provided by investing activities | — | — | — | 2,565,000 | — | — | — | 1,919,000 |
| Cash flows from financing activities: | ||||||||
| Net increase in deposits | — | — | — | 829,000 | — | — | — | (2,703,000) |
| Treasury stock purchased | — | — | — | (117,000) | — | — | — | — |
| Net change in short-term borrowings | — | — | — | 0 | — | — | — | (425,000) |
| Net change in mortgagors' escrow accounts | — | — | — | 65,000 | — | — | — | 30,000 |
| Net cash provided by financing activities | — | — | — | 777,000 | — | — | — | (3,098,000) |
| Net change in cash and cash equivalents | — | — | — | 3,708,000 | — | — | — | (743,000) |
| Cash and cash equivalents at beginning of period | 28,250,000 | 28,829,000 | 30,667,000 | 26,959,000 | 21,664,000 | 15,724,000 | 6,118,000 | 6,861,000 |
| Cash and cash equivalents at end of period | 24,665,000 | 28,250,000 | 28,829,000 | 30,667,000 | 26,959,000 | 21,664,000 | 15,724,000 | 6,118,000 |
| Supplemental information: | ||||||||
| Interest paid on deposits and short term borrowings | — | — | — | 1,607,000 | — | — | — | 913,000 |
| Income taxes paid | — | — | — | 20,000 | — | — | — | 65,000 |
| Adoption of ASU 2016-02 | — | — | — | — | — | — | — | 0 |
| Adoption of ASU 2016-13 | — | — | — | 0 | — | — | — | 223,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.